Citation: | WANG Xiniao, YAO Wenhui, PAN Zhenzhen, DONG Jieyan, LIU Shuo, DING Xuansheng. Protective effects and mechanism of icariin against vascular function in diabetic mice[J]. Journal of China Pharmaceutical University, 2022, 53(2): 215-221. DOI: 10.11665/j.issn.1000-5048.20220212 |
[1] |
. BMJ,2020,369:
|
[2] |
Tseng CH. Mortality and causes of death in a national sample of diabetic patients in Taiwan[J]. Diabetes Care,2004,27(7):1605-1609.
|
[3] |
Song LJ,Chen X,Mi L,et al. Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer[J]. Cancer Sci,2020,111(11):4242-4256.
|
[4] |
Qi SS,He J,Zheng HX,et al. Icariin prevents diabetes-induced bone loss in rats by reducing blood glucose and suppressing bone turnover[J]. Molecules,2019,24(10):1871.
|
[5] |
Cao LH,Qiao JY,Huang HY,et al. PI3K-AKT signaling activation and icariin:the potential effects on the perimenopausal depression-like rat model[J]. Molecules,2019,24(20):3700.
|
[6] |
Angeloni C,Barbalace MC,Hrelia S. Icariin and its metabolites as potential protective phytochemicals against Alzheimer''s disease[J]. Front Pharmacol,2019,10:271.
|
[7] |
Li X,Wang YX,Shi P,et al. Icariin treatment reduces blood glucose levels in type 2 diabetic rats and protects pancreatic function[J]. Exp Ther Med,2020,19(4):2690-2696.
|
[8] |
Qiao C,Wang H,Song ZY,et al. Icariin attenuates diabetic cardiomyopathy and downregulates extracellular matrix proteins in heart tissue of type 2 diabetic rats[J]. Pharmacology,2020,105(9/10):576-585.
|
[9] |
Yao WH,Wang K,Wang XN,et al. Icariin ameliorates endothelial dysfunction in type 1 diabetic rats by suppressing ER stress via the PPARα/Sirt1/AMPKα pathway[J]. J Cell Physiol,2021,236(3):1889-1902.
|
[10] |
Chen SS,Wang ZY,Zhou H,et al. Icariin reduces high glucose-induced endothelial progenitor cell dysfunction via inhibiting the p38/CREB pathway and activating the Akt/eNOS/NO pathway[J]. Exp Ther Med,2019,18(6):4774-4780.
|
[11] |
Huang ZJ,Ji H,Li P,et al. Hypoglycemic effect and mechanism of polysaccharides from cultured mycelium of cordyceps sinensis[J]. J China Pharm Univ(中国药科大学学报),2002,33(1):51-54.
|
[12] |
Jia GH,Hill MA,Sowers JR. Diabetic cardiomyopathy:an update of mechanisms contributing to this clinical entity[J]. Circ Res,2018,122(4):624-638.
|
[13] |
Shi Y,Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes[J]. J Diabetes,2017,9(5):434-449.
|
[14] |
Vita JA,Keaney JF
|
[15] |
Xiao HB,Liu ZK,Lu XY,et al. Icariin regulates PRMT/ADMA/DDAH pathway to improve endothelial function[J]. Pharmacol Rep,2015,67(6):1147-1154.
|
[16] |
Vanhoutte PM. Endothelial control of vasomotor function:from health to coronary disease[J]. Circ J,2003,67(7):572-575.
|
[17] |
Lee YN,Im E. Regulation of miRNAs by natural antioxidants in cardiovascular diseases:focus on SIRT1 and eNOS[J]. Antioxidants (Basel),2021,10(3):377.
|
[18] |
Papaconstantinou J. The role of signaling pathways of inflammation and oxidative stress in development of senescence and aging phenotypes in cardiovascular disease[J]. Cells,2019,8(11):1383.
|
[19] |
Leng B,Li C,Sun Y,et al. Protective effect of astragaloside IV on high glucose-induced endothelial dysfunction via inhibition of P2X7R dependent P38 MAPK signaling pathway[J]. Oxid Med Cell Longev,2020,2020:5070415.
|
[20] |
Steven S,Frenis K,Oelze M,et al. Vascular inflammation and oxidative stress:major triggers for cardiovascular disease[J]. Oxid Med Cell Longev,2019,2019:7092151.
|